DESIGN, SYNTHESIS, AND ACTIVITY OF CONFORMATIONALLY-CONSTRAINED MACROCYCLIC PEPTIDE-BASED INHIBITORS OF HIV PROTEASE

被引:18
作者
SMITH, RA [1 ]
COLES, PJ [1 ]
CHEN, JJ [1 ]
ROBINSON, VJ [1 ]
MACDONALD, ID [1 ]
CARRIERE, J [1 ]
KRANTZ, A [1 ]
机构
[1] SYNTEX RES CANADA,MISSISSAUGA,ON,CANADA
关键词
D O I
10.1016/S0960-894X(00)80074-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Conformationally-constrained macrocyclic peptide-based hydroxyethylamines, with 17- to 19-membered ring systems, have been designed and synthesized as HIV protease inhibitors. Structure-activity relationships were consistent with molecular modeling studies, and certain cyclic inhibitors were developed with HIV protease IC50 values of similar to-1 nM, and antiviral activities (HIV-1/RF infected MT-2 cells) of EC(50) 4-8 nM.
引用
收藏
页码:2217 / 2222
页数:6
相关论文
共 28 条
[1]  
ANTEUNIS MJO, 1987, B SOC CHIM BELG, V96, P133
[2]  
ANTEUNIS MJO, 1987, B SOC CHIM BELG, V96, P119
[3]  
BROTHERTONPLEIS.CE, 1992, PEPTIDES CHEM BIOL, P816
[4]   THE SYNTHESIS OF POTENT MACROCYCLIC RENIN INHIBITORS [J].
DHANOA, DS ;
PARSONS, WH ;
GREENLEE, WJ ;
PATCHETT, AA .
TETRAHEDRON LETTERS, 1992, 33 (13) :1725-1728
[5]  
HANDA BK, 1989, Patent No. 34684
[6]   HIV PROTEASE - A NOVEL CHEMOTHERAPEUTIC TARGET FOR AIDS [J].
HUFF, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) :2305-2314
[7]   PRESENT STATUS AND FUTURE-PROSPECTS FOR HIV THERAPIES [J].
JOHNSTON, MI ;
HOTH, DF .
SCIENCE, 1993, 260 (5112) :1286-1293
[8]   STRUCTURE-BASED, C2 SYMMETRICAL INHIBITORS OF HIV PROTEASE [J].
KEMPF, DJ ;
NORBECK, DW ;
CODACOVI, LM ;
WANG, XC ;
KOHLBRENNER, WE ;
WIDEBURG, NE ;
PAUL, DA ;
KNIGGE, MF ;
VASAVANONDA, S ;
CRAIGKENNARD, A ;
SALDIVAR, A ;
ROSENBROOK, W ;
CLEMENT, JJ ;
PLATTNER, JJ ;
ERICKSON, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) :2687-2689
[9]   NOVEL BINDING MODE OF HIGHLY POTENT HIV-PROTEINASE INHIBITORS INCORPORATING THE (R)-HYDROXYETHYLAMINE ISOSTERE [J].
KROHN, A ;
REDSHAW, S ;
RITCHIE, JC ;
GRAVES, BJ ;
HATADA, MH .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (11) :3340-3342
[10]   RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS [J].
LAM, PYS ;
JADHAV, PK ;
EYERMANN, CJ ;
HODGE, CN ;
RU, Y ;
BACHELER, LT ;
MEEK, JL ;
OTTO, MJ ;
RAYNER, MM ;
WONG, YN ;
CHANG, CH ;
WEBER, PC ;
JACKSON, DA ;
SHARPE, TR ;
ERICKSONVIITANEN, S .
SCIENCE, 1994, 263 (5145) :380-384